Revised controlled substances policy and
forms take effect June 1
The Individual Investigator Use of Controlled Substances in Non-Therapeutic Research
policy describes the responsibilities of the university, registrants and authorized agents who use controlled substances in animal, cell culture or in-vitro analytical laboratory research. The policy specifically addresses responsibilities to comply with DEA and State of Ohio Board of Pharmacy requirements concerning the administration, handling, storage, destruction and/or transfer of controlled substances used in such research.
The policy revision, which is effective June 1, 2016:
- incorporates regulation changes
- requires background checks to be performed for anyone with access to controlled substances
- centralizes registration and administration at the college level
- sets training and inspection standards
- standardizes record keeping requirements
- formalizes current university practices and provides clarity for a university-wide audience
An overview of the university’s controlled substances program and updated, required forms to be used for documenting the receipt, use, waste, loss/theft, transfer or disposal of controlled substances in research as well as authorized agent lists are available on the “Controlled Substances
” page of the Office of Research Compliance website.
For answers to frequently asked questions, visit http://orc.osu.edu/regulations-policies/controlled-substances/faqs/
View the entire revised Individual Investigator Use of Controlled Substances in Non-Therapeutic Research policy at http://policies.osu.edu/ (available after June 1).